ADVI Health teamed up with Mix Talent in a special edition podcast on cell and gene therapy. In this two-part series, Melyssa Nocar, head of marketing at ADVI, and Paige Nelson, head of business development at Mix Talent, bring together women leaders in cell and gene to discuss the journey from manufacturing to commercialization, providing a forum to share experience, areas of expertise, and insights for the future.

This second episode features a discussion on the approval and post-approval process in the journey to commercialization. Abbey Jenkins, CEO of Gamida Cell, and Izzy Tyszler, vice president of marketing at Zevra Therapeutics, join Alicia Silver, director of health policy and reimbursement at ADVI, to discuss key learnings from past commercialization experiences, how to prepare for commercialization, and the challenges and opportunities facing the cell and gene therapy industry today.

You can listen in here if you missed the first episode, which focused on drug development and manufacturing.

The Mix Tape Ep 2 from ADVI on Vimeo.